Variable | No of patients | Univariate P | Multivariate P | HR | 95% CI | |
Age | <70 ≥70 | n = 17 n = 21 | 0.45 |
|
|
|
Gender | M F | n = 17 n = 21 | 0.39 |
|
|
|
WBC (/μl) | <6500 ≥6500 | n = 13 n = 25 | 0.72 |
|
|
|
Neutrophil (/μl) | <5000 ≥5000 | n = 17 n = 21 | 0.36 |
|
|
|
Lymphcyte (/μl) | <1200 ≥1200 | n = 15 n = 23 | 0.82 |
|
|
|
NLR | <5 ≥5 | n = 25 n = 13 | 0.01 | 0.03 | 2.8 | 1.1 - 6.6 |
AST (IU/l) | <20 ≥20 | n = 8 n = 30 | 0.31 |
|
|
|
ALT (IU/l) | <30 ≥30 | n = 28 n = 10 | <0.01 | <0.01 | 5.0 | 1.9 - 13.1 |
T.Bil (mg/dl) | <0.8 ≥0.8 | n = 29 n = 9 | 0.88 |
|
|
|
T.P (g/dl) | <6.0 ≥6.0 | n = 5 n = 33 | 0.66 |
|
|
|
Alb (g/dl) | <3.5 ≥3.5 | n = 15 n = 23 | 0.72 |
|
|
|
CEA (ng/ml) | <5.0 ≥5.0 | n = 3 n = 35 | 0.06 |
|
|
|
CA19-9 (U/ml) | <60 ≥60 | n = 11 n = 27 | 0.94 |
|
|
|
CRP (mg/dl) | <1 ≥1 | n = 18 n = 20 | 0.52 |
|
|
|
GPS | <1 ≥1 | n = 14 n = 24 | 0.73 |
|
|
|
Tumor location | Colon Rectum | n = 34 n = 4 | 0.31 |
|
|
|
Pathology | Diff Non Diff | n = 32 n = 6 | 0.19 |
|
|
|
Serosal invasion | Yes No | n = 28 n = 10 | 0.95 |
|
|
|
Vascular invasion | Yes No | n = 32 n = 6 | 0.38 |
|
|
|
Lymphatic invasion | Yes No | n = 27 n = 11 | 0.64 |
|
|
|
Lymph-node metastasis | Yes No | n = 28 n = 10 | 0.48 |
|
|
|
Hepatic metastasis | Yes No | n = 4 n = 34 | 0.59 |
|
|
|
Lung metastasis | Yes No | n = 13 n = 25 | 0.21 |
|
|
|
Peritoneal metastasis | Yes No | n = 6 n = 32 | 0.24 |
|
|
|
Chemotherapy | Yes No | n = 26 n = 12 | 0.01 | <0.01 | 3.5 | 1.5 - 8.1 |